Gregg R.  Honigblum net worth and biography

Gregg Honigblum Biography and Net Worth

Chief Investment Officer and Member of the Board of Sintx Technologies

Mr. Honigblum has served as the Company’s Chief Investment Officer since April 2025. Previously Mr. Honigblum acted as our Chief Strategy Officer from November 2024 to April 2025. Honigblum began his professional career as a stockbroker on Wall Street before transitioning into investment banking at several boutique firms in New York City. He co-founded Creation Capital LLC and Creation Capital Advisors, investment banking firms based in New York and Austin, Texas, which focused on founding and funding innovative healthcare technologies. Mr. Honigblum, through Creation Capital provided over $100 million in private equity to Amedica (SINTX’s predecessor).
Honigblum also was instrumental in providing early-stage capital for Myriad Genetics, the first precision medicine diagnostic company credited with discovering the BRCA1 and BRCA2 breast cancer genes. He was also an early investor and financier for Acacia Biosciences, which merged with Rosetta Inpharmatics and was later acquired by Merck for $620 million.
Honigblum holds Series 7, 24, and 63 Securities licenses(inactive), and earned a Bachelor of Arts degree in Economics from the University of Texas at Austin.

What is Gregg R. Honigblum's net worth?

The estimated net worth of Gregg R. Honigblum is at least $425.26 thousand as of December 8th, 2025. Mr. Honigblum owns 201,067 shares of Sintx Technologies stock worth more than $425,257 as of October 7th. This net worth approximation does not reflect any other investments that Mr. Honigblum may own. Learn More about Gregg R. Honigblum's net worth.

How do I contact Gregg R. Honigblum?

The corporate mailing address for Mr. Honigblum and other Sintx Technologies executives is 1885 West 2100 Street, Salt Lake City, UT, 84119. Sintx Technologies can also be reached via phone at (855) 839-3500 and via email at [email protected]. Learn More on Gregg R. Honigblum's contact information.

Has Gregg R. Honigblum been buying or selling shares of Sintx Technologies?

Gregg R. Honigblum has not been actively trading shares of Sintx Technologies over the course of the past ninety days. Most recently, on Monday, December 8th, Gregg R. Honigblum bought 8,200 shares of Sintx Technologies stock. The stock was acquired at an average cost of $4.26 per share, with a total value of $34,932.00. Following the completion of the transaction, the executive now directly owns 201,067 shares of the company's stock, valued at $856,545.42. Learn More on Gregg R. Honigblum's trading history.

Who are Sintx Technologies' active insiders?

Sintx Technologies' insider roster includes Gregg Honigblum (Chief Investment Officer and Member of the Board), Christopher Lyons (Director), and Eric Olson (Chief Executive Officer and Chairman of the Board). Learn More on Sintx Technologies' active insiders.

Are insiders buying or selling shares of Sintx Technologies?

During the last twelve months, Sintx Technologies insiders bought shares 8 times. They purchased a total of 101,292 shares worth more than $378,064.28. The most recent insider tranaction occured on March, 2nd when Director Christopher Michael Lyons bought 7,534 shares worth more than $21,848.60. Insiders at Sintx Technologies own 4.1% of the company. Learn More about insider trades at Sintx Technologies.

Information on this page was last updated on 3/2/2026.

Gregg R. Honigblum Insider Trading History at Sintx Technologies

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/8/2025Buy8,200$4.26$34,932.00201,067View SEC Filing Icon  
12/5/2025Buy65,000$3.93$255,450.00139,000View SEC Filing Icon  
11/7/2025Buy10,000$3.19$31,900.0074,000View SEC Filing Icon  
8/26/2025Buy50,000$3.70$185,000.0064,000View SEC Filing Icon  
4/22/2025Buy10,000$1.77$17,700.0010,000View SEC Filing Icon  
See Full Table

Gregg R. Honigblum Buying and Selling Activity at Sintx Technologies

This chart shows Gregg R. Honigblum's buying and selling at Sintx Technologies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Sintx Technologies Company Overview

Sintx Technologies logo
Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
Read More

Today's Range

Now: $2.16
Low: $2.05
High: $2.20

50 Day Range

MA: $1.73
Low: $1.49
High: $2.23

2 Week Range

Now: $2.16
Low: $1.40
High: $4.64

Volume

22,856 shs

Average Volume

65,802 shs

Market Capitalization

$9.33 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A